Please login to the form below

Not currently logged in
Email:
Password:

methotrexate

This page shows the latest methotrexate news and features for those working in and with pharma, biotech and healthcare.

London cancer hub launched by Cancer Research UK

London cancer hub launched by Cancer Research UK

I’m still in remission – every three months I have a small dose of methotrexate into my spine to protect my brain in case the cancer comes back, and I have

Latest news

More from news
Approximately 2 fully matching, plus 102 partially matching documents found.

Latest appointments

  • Antares appoints David Bergstrom as SVP Antares appoints David Bergstrom as SVP

    The appointments come as the company looks to expand its business after the commercialisation of Otrexup (methotrexate) for arthritis and the advance in development of testosterone replacement therapy Vibex QS T.

  • Former Pfizer VP joins Antares Former Pfizer VP joins Antares

    methotrexate) for arthritis and advance the development of testosterone replacement therapy Vibex QS T. “

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics